TRNS — Transcat, Inc.
TRNS dilution and offerings
- Dilution risk: Low
- Active shelf: S-3ASR (Sep 2026)
- Float: 9.1M shares
Dilution filings
- S-3ASR
🔔 Alert me if TRNS files an offering or S-3
$89.52+1.82%
Last close: · regular session
Pre-market $99.19 +10.81% ·
Last 60 sessions
Dilution risk: low; active automatic shelf (S-3ASR, Sep 2026). Float: 9.1M shares. Latest SEC filing: 10-Q on Nov 3, 2026. TRNS closed at $89.52 (+1.82%) on Nov 3, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for TRNS in the TickerWise workspace.
Company profile
- Sector: Industrials
- Industry: Industrial - Distribution
- Country: US
- Exchange: NASDAQ
- Employees: 1,104
- Website: https://www.transcat.com
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
Latest SEC filings for TRNS
Latest TRNS news
- Transcat raises FY2027 service organic growth outlook to low double digits while targeting at least 100 bps service gross margin expansion in 2H Read article
- Transcat Non-GAAP EPS of $0.64 beats by $0.19, revenue of $97.1M beats by $4.64M Read article
- Is the Options Market Predicting a Spike in Transcat Stock? Read article
- Can Transcat (TRNS) Keep the Earnings Surprise Streak Alive? Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.